Tackling Dyslipidemia in Obesity from a Nanotechnology Perspective

Tackling Dyslipidemia in Obesity from a Nanotechnology Perspective

Obesity and dyslipidemia are the main features of metabolic syndrome, expressed mainly by adipose tissue dysfunction and connected by similar pathways and pharmacotherapy. Conventional drugs used in these two associated disorders are limited due to poor drug efficiency, non-specificity, and toxic si...

Full description

Bibliographic Details
Main Authors: Laura M. Trandafir, Gianina Dodi, Otilia Frasinariu, Alina C. Luca, Lacramioara I. Butnariu, Elena Tarca, Stefana M. Moisa
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Nutrients
Subjects:
dyslipidemia
obesity
nanotechnology
drug delivery
natural products
Online Access:https://www.mdpi.com/2072-6643/14/18/3774

Internet

https://www.mdpi.com/2072-6643/14/18/3774

Similar Items